$134.44
0.25%
NYSE, Jul 03, 09:30 pm CET
ISIN
US0028241000
Symbol
ABT

Abbott Laboratories Stock price

$134.44
+0.73 0.55% 1M
+20.61 18.11% 6M
+21.33 18.86% YTD
+32.11 31.38% 1Y
+24.22 21.97% 3Y
+42.21 45.77% 5Y
+85.03 172.09% 10Y
+110.98 473.07% 20Y
NYSE, Closing price Thu, Jul 03 2025
+0.33 0.25%
ISIN
US0028241000
Symbol
ABT
Sector

Key metrics

Basic
Market capitalization
$233.9b
Enterprise Value
$240.3b
Net debt
$6.4b
Cash
$6.8b
Shares outstanding
1.7b
Valuation (TTM | estimate)
P/E
17.4 | 25.8
P/S
5.5 | 5.2
EV/Sales
5.7 | 5.3
EV/FCF
36.1
P/B
4.8
Dividends
DPS
$2.24
Yield 1Y | 5Y
1.7% | 1.8%
Growth 1Y | 5Y
7.7% | 11.2%
Payout 1Y | 3Y
29.2% | 42.0%
Increased
11 Years
Financials (TTM | estimate)
Revenue
$42.3b | $45.1b
EBITDA
$9.2b | $12.2b
EBIT
$7.4b | $10.4b
Net Income
$13.5b | $9.1b
Free Cash Flow
$6.7b
Growth (TTM | estimate)
Revenue
5.0% | 7.6%
EBITDA
7.9% | 37.1%
EBIT
12.0%
Net Income
139.8% | -32.3%
Free Cash Flow
35.2%
Margin (TTM | estimate)
Gross
56.1%
EBITDA
21.8% | 27.0%
EBIT
17.5%
Net
31.9% | 20.1%
Free Cash Flow
15.7%
Financial Health
Equity Ratio
58.6%
Return on Equity
28.1%
ROCE
10.8%
ROIC
19.7%
Debt/Equity
0.3
More
EPS
$7.7
FCF per Share
$3.8
Short interest
1.2%
Employees
114k
Rev per Employee
$370.0k
Show more

Is Abbott Laboratories a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,967 stocks worldwide.

Abbott Laboratories Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Abbott Laboratories forecast:

21x Buy
64%
12x Hold
36%

Analyst Opinions

33 Analysts have issued a Abbott Laboratories forecast:

Buy
64%
Hold
36%

Financial data from Abbott Laboratories

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
42,344 42,344
5% 5%
100%
- Direct Costs 18,589 18,589
3% 3%
44%
23,755 23,755
7% 7%
56%
- Selling and Administrative Expenses 11,748 11,748
6% 6%
28%
- Research and Development Expense 2,790 2,790
5% 5%
7%
9,217 9,217
8% 8%
22%
- Depreciation and Amortization 1,826 1,826
6% 6%
4%
EBIT (Operating Income) EBIT 7,391 7,391
12% 12%
17%
Net Profit 13,502 13,502
140% 140%
32%

In millions USD.

Don't miss a Thing! We will send you all news about Abbott Laboratories directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Abbott Laboratories Stock News

Positive
The Motley Fool
about 21 hours ago
In 2013, AbbVie (ABBV -0.93%) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (ABT 0.18%). Since then, both have produced strong returns and have been great picks for income-seeking investors, thanks to consistent payout hikes.
Positive
Seeking Alpha
7 days ago
Abbott's proactive leadership and diversified business model help it navigate macro challenges and market volatility effectively. Strong Q1 performance in Nutrition, Medical Devices, and Vascular segments offsets weakness in Diagnostics and China sales, showcasing resilience and adaptability. Management's focus on gross margin expansion, cost-saving initiatives, and shareholder-friendly policie...
Positive
Seeking Alpha
7 days ago
Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before, potentially resulting in a 15% CAGR in FreeStyle Libre sales by 2028. With Abbott acquiring rights to 4 more biosimilar products and a double-digit CAGR in the target biosimilar emerging markets, the EPD business could stimulate EPS growth beyond Medical Devices. With an ...
More Abbott Laboratories News

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Head office United States
CEO Robert Ford
Employees 114,000
Founded 1888
Website www.abbott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today